With battles over the future of American health care being waged in the courts and at the ballot box, JAMA, the Journal of the American Medical Association, has devoted its latest issue to better understanding what Deputy Editor Gregory Curfman called the "challenging problem" of "relentless increases" in prescription drug prices.